| Title |
Steroid-resistant nephrotic syndrome: past and current perspectives
|
|---|---|
| Published in |
Pediatric Health, Medicine and Therapeutics, April 2017
|
| DOI | 10.2147/phmt.s100803 |
| Pubmed ID | |
| Authors |
Noureddin Nourbakhsh, Robert H Mak |
| Abstract |
Patients with steroid-resistant nephrotic syndrome (SRNS) represent a challenging subset of patients with nephrotic syndrome who often fail standard immunosuppression and have a higher likelihood of progressing to end-stage renal disease. Appropriate treatment of SRNS requires an adequate understanding of the historical treatment, renal histopathology, and genetics associated with the disease. The aim of this review is to present a comprehensive appraisal of the history, role of renal biopsy, genetics, and treatment of SRNS. |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 2 | 17% |
| United Kingdom | 2 | 17% |
| Venezuela, Bolivarian Republic of | 1 | 8% |
| Brazil | 1 | 8% |
| India | 1 | 8% |
| Unknown | 5 | 42% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 67% |
| Practitioners (doctors, other healthcare professionals) | 3 | 25% |
| Scientists | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 129 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 19 | 15% |
| Student > Master | 16 | 12% |
| Student > Postgraduate | 13 | 10% |
| Other | 10 | 8% |
| Student > Ph. D. Student | 8 | 6% |
| Other | 10 | 8% |
| Unknown | 53 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 43 | 33% |
| Biochemistry, Genetics and Molecular Biology | 10 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 8% |
| Agricultural and Biological Sciences | 3 | 2% |
| Nursing and Health Professions | 2 | 2% |
| Other | 7 | 5% |
| Unknown | 54 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2023.
All research outputs
#2,559,964
of 25,507,011 outputs
Outputs from Pediatric Health, Medicine and Therapeutics
#21
of 174 outputs
Outputs of similar age
#46,332
of 324,255 outputs
Outputs of similar age from Pediatric Health, Medicine and Therapeutics
#2
of 5 outputs
Altmetric has tracked 25,507,011 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 174 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,255 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.